A Phase 1b Study of LY2835219 in Combination with Multiple Single-Agent Options for Patients with Stage IV NSCLC

Type of Cancer
Lung

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase 1b Study of LY2835219 in Combination with Multiple Single-Agent Options for Patients with Stage IV NSCLC

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.